The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Anti‐tumor mechanisms of valproate: A novel role for an old drug
Abstract
Valproic acid (VPA, 2‐propylpentanoic acid) is an established drug in the long‐term therapy of epilepsy. During the past years, it has become evident that VPA is also associated with anti‐cancer activity. VPA not only suppresses tumor growth and metastasis, but also induces tumor differentiation in vitro and in vivo. Several modes of action might be relevant for the biological activity of VPA: (1) VPA increases the DNA binding of activating protein‐1 (AP‐1) transcription factor, and the expression of genes regulated by the extracellular‐regulated kinase (ERK)‐AP‐1 pathway; (2) VPA downregulates protein kinase C (PKC) activity; (3) VPA inhibits glycogen synthase kinase‐3β (GSK‐3β), a negative regulator of the Wnt signaling pathway; (4) VPA activates the peroxisome proliferator‐activated receptors PPARγ and †; (5) VPA blocks HDAC (histone deacetylase), causing hyperacetylation. The findings elucidate an important role of VPA for cancer therapy. VPA might also be useful as low toxicity agent given over long time periods for chemoprevention and/or for control of residual minimal disease. © 2002 Wiley Periodicals, Inc. Med Res Rev, 22, No. 5, 492–511, 2002; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/med.10017
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
Linking Colorectal Cancer to Wnt Signaling
Bienz, M., & Clevers, H. (2000) · Cell · doi:10.1016/s0092-8674(00)00122-7 · Cited by 1,515
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Richon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 857
What's Up and Down with Histone Deacetylation and Transcription?
Pazin, M. J., & Kadonaga, J. T. (1997) · Cell · doi:10.1016/s0092-8674(00)80211-1 · Cited by 821
Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ceña, V., Gallego, C., & Comella, J. X. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750991.x · Cited by 820
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J.-E., Lee, S.-W., Moon, E.-J., Kim, H.-S., Lee, S.-K., Chung, H. Y., et al. (2001) · Nature Medicine · doi:10.1038/86507 · Cited by 731
Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways
Miller, J. R., Hocking, A. M., Brown, J. D., & Moon, R. T. (1999) · Oncogene · doi:10.1038/sj.onc.1203245 · Cited by 691
(1996) · Europe PMC (PubMed Central) · Cited by 659
Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999) · Circulation · doi:10.1161/01.cir.99.24.3125 · Cited by 599
Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action
Löscher, W. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00075-6 · Cited by 532
Pasceri, V., Wu, H. D., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.101.3.235 · Cited by 504
Vigushin, D. M., Ali, S., Pace, P., Mirsaidi, N., Ito, K., Adcock, I. M., & Coombes, R. C. (2001) · PubMed · Cited by 447
The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 438
Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D. S., Oh, W., Demetri, G., Figg, W. D., Zhou, X.-P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180329197 · Cited by 426
Michalik, L., Desvergne, B., Tan, N. S., Basu-Modak, S., Escher, P., Rieusset, J., Peters, J. M., Kaya, G., Gonzalez, F. J., Zakany, J., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200011148 · Cited by 406
Sambucetti, L. C., Fischer, D. D., Zabludoff, S., Kwon, P. O., Chamberlin, H., Trogani, N., Xu, H., & Cohen, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34940 · Cited by 390
Chang, T.-H., & Szabo, E. M. (2000) · PubMed · Cited by 385
Jackson, S. M., Parhami, F., Xi, X.-P., Berliner, J. A., Hsueh, W. A., Law, R. E., & Demer, L. L. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2094 · Cited by 373
Cloning of a Protein That Mediates Transcriptional Effects of Fatty Acids in Preadipocytes
Amri, E.-Z., Bonino, F., Ailhaud, G., Abumrad, N. A., & Grimaldi, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2367 · Cited by 368
Patel, L., Pass, I., Coxon, P., Downes, C. P., Smith, S. A., & Macphee, C. H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00225-1 · Cited by 365
Mechanism of anticonvulsant action of valproate
Chapman, A., Keane, P. E., Meldrum, B. S., Simiand, J., & Vernieres, J. C. (1982) · Progress in Neurobiology · doi:10.1016/0301-0082(82)90010-7 · Cited by 337
Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation
Leppa, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4404 · Cited by 335
Yuan, P.-X., Huang, L.-D., Jiang, Y.-M., Gutkind, J. S., Manji, H. K., & Chen, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104309200 · Cited by 332
Tsubouchi, Y., Sano, H., Kawahito, Y., Mukai, S., Yamada, R., Kohno, M., Inoue, K.-I., Hla, T., & Kondo, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2436 · Cited by 315
BROCKMAN, J., GUPTA, R., & DUBOIS, R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70072-1 · Cited by 313
Protein Kinases as Mediators of Phosphoinositide 3-Kinase Signaling
Toker, A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26463-4 · Cited by 304
Differentiation therapy of human cancer: basic science and clinical applications
Leszczyniecka, M., Roberts, T., Dent, P., Grant, S., & Fisher, P. B. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00132-2 · Cited by 292
PTEN, a unique tumor suppressor gene.
Dahia, P. L. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070115 · Cited by 283
David, G., Alland, L., Hong, S.-H., Wong, C.-W., DePinho, R. A., & Dejean, A. (1998) · Oncogene · doi:10.1038/sj.onc.1202043 · Cited by 281
Encinas, M., Iglesias, M., Llecha, N., & Comella, J. X. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731409.x · Cited by 278
Han, J. W., Ahn, S. H., Park, S. H., Wang, S. Y., Bae, G., Seo, D. W., Kwon, H. K., Hong, S., Lee, H. Y., Lee, Y., et al. (2000) · PubMed · Cited by 273
VALPROIC ACID AND SPINA BIFIDA
Bjerkedal, T., Czeizel, A., Goujard, J., Kallen, B., Mastroiacova, P., Nevin, N., Oakley, G., & Robert, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90018-6 · Cited by 265
Cell growth control by G protein-coupled receptors: from signal transduction to signal integration
Gutkind, J. S. (1998) · Oncogene · doi:10.1038/sj.onc.1202186 · Cited by 261
Kitamura, S., Miyazaki, Y., Shinomura, Y., Kondo, S., Kanayama, S., & Matsuzawa, Y. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00668.x · Cited by 257
Histone Acetylation and Chromatin Assembly: A Single Escort, Multiple Dances?
Roth, S. Y., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81316-1 · Cited by 248
Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis
Fajas, L., Debril, M., & Auwerx, J. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0270001 · Cited by 231
Whalen, A. M., Galasinski, S. C., Shapiro, P. S., Nahreini, T. S., & Ahn, N. G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1947 · Cited by 231
DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors.
Zhu, W., Lakshmanan, R. R., Beal, M. D., & Otterson, G. A. (2001) · PubMed · Cited by 226
The Peroxisome Proliferator‐activated Receptors: Ligands and Activatorsa
FORMAN, B. M., CHEN, J., & EVANS, R. M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18621.x · Cited by 218
Billin, A. N., Thirlwell, H., & Ayer, D. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6882-6890.2000 · Cited by 216
Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
Nakajima, A., Wada, K., Miki, H., Kubota, N., Nakajima, N., Terauchi, Y., Ohnishi, S., Saubermann, L. J., Kadowaki, T., Blumberg, R. S., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.21191 · Cited by 216
Target Genes of Peroxisome Proliferator-activated Receptor γ in Colorectal Cancer Cells
Gupta, R. A., Brockman, J. A., Sarraf, P., Willson, T. M., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103779200 · Cited by 215
Inhibitors of Histone Deacetylase as New Anticancer Agents
Jung, M. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372058 · Cited by 213
Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis
Neve, B. P., Fruchart, J.-C., & Staels, B. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00430-5 · Cited by 211
Motomura, W., Okumura, T., Takahashi, N., OBARA, T., & Kohgo, Y. (2000) · PubMed · doi:10.11501/3186319 · Cited by 209
Shappell, S. B., Gupta, R. A., Manning, S., Whitehead, R. H., Boeglin, W. E., Schneider, C. G., Case, T., Price, J. O., Jack, G. S., Wheeler, T. M., et al. (2001) · PubMed · Cited by 207
Peroxisome proliferator-activated receptor agonists
Willson, T. M., & Wahli, W. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80015-4 · Cited by 198
Kwon, H. J., Owa, T., Hassig, C. A., Shimada, J., & Schreiber, S. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3356 · Cited by 197
Sodium valproate inhibits production of TNF-α and IL-6 and activation of NF-κB
Ichiyama, T., Okada, K., Lipton, J. M., Matsubara, T., Hayashi, T., & Furukawa, S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02439-7 · Cited by 196
Troussard, A. A., Costello, P., Yoganathan, T. N., Kumagai, S., Roskelley, C. D., & Dedhar, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203928 · Cited by 180
Koga, H., Sakisaka, S., Harada, M., Takagi, T., Hanada, S., Taniguchi, E., Kawaguchi, T., Sasatomi, K., Kimura, R., Hashimoto, O., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24024 · Cited by 175
Molecular control of neural crest formation, migration and differentiation
Christiansen, J. H., Coles, E. G., & Wilkinson, D. G. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00158-7 · Cited by 172
Chronic Sodium Valproate Selectively Decreases Protein Kinase C α and ε In Vitro
Chen, G., Manji, H. K., Hawver, D. B., Wright, C. B., & Potter, W. Z. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062361.x · Cited by 171
Lefebvre, M., Paulweber, B., Fajas, L., Woods, J., McCrary, C., Colombel, J., Najib, J., Fruchart, J., Datz, C., Vidal, H., et al. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1620331 · Cited by 167
Minucci, S., Nervi, C., Coco, F. L., & Pelicci, P. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204336 · Cited by 163
Somatic mutations ofWNT/wingless signaling pathway components in primitive neuroectodermal tumors
Koch, A., Waha, A., Tonn, J. C., S�rensen, N., Berthold, F., Wolter, M., Reifenberger, J., Hartmann, W., Friedl, W., Reifenberger, G., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1342 · Cited by 160
Kim, B., Leventhal, P. S., Saltiel, A. R., & Feldman, E. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21268 · Cited by 156
Induction of neurite outgrowth by MAP kinase in PC12 cells.
Fukuda, M., Gotoh, Y., Tachibana, T., Dell, K. R., Hattori, S., Yoneda, Y., & Nishida, E. (1995) · PubMed · Cited by 148
Hisatake, J., Ikezoe, T., Carey, M., Holden, S. A., Tomoyasu, S., & Koeffler, H. P. (2000) · PubMed · Cited by 146
Komatsu, Y., Tomizaki, K., Tsukamoto, M., Kato, T., Nishino, N., Sato, S., Yamori, T., Tsuruo, T., Furumai, R., Yoshida, M., et al. (2001) · PubMed · Cited by 145
Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada, M., Krajewski, S., Tanaka, S., Cazals-Hatem, D. L., Spengler, B. A., Ross, R. A., Biedler, J. L., & Reed, J. C. (1993) · PubMed · Cited by 138
Histone deacetylase inhibitors as potential anti-skin cancer agents.
Saunders, N. A., Dicker, T., Popa, C., Jones, S. J. M., & Dahler, A. L. (1999) · PubMed · Cited by 137
Guo, Y.-S., Hellmich, M. R., Wen, X. D., & Townsend, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101801200 · Cited by 120
Kermorgant, S., Aparicio, T., Dessirier, V., Lewin, M. J. M., & Lehy, T. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.1035 · Cited by 119
Rashid, S. F., Moore, J. S., Walker, E. S., Driver, P. M., Engel, J., Edwards, C. E., Brown, G., Uskoković, M. R., & Campbell, M. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204269 · Cited by 119
1,25-Dihydroxyvitamin D3 Stimulates Activator Protein-1-dependent Caco-2 Cell Differentiation
Chen, A., Davis, B. H., Bissonnette, M., Scaglione-Sewell, B., & Brasitus, T. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35505 · Cited by 118
Mechanism of Cell Cycle Arrest Caused by Histone Deacetylase Inhibitors in Human Carcinoma Cells.
Kim, Y. B., Ki, S. W., YOSNIDA, M., & Horinouchi, S. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.1191 · Cited by 117
Cheung, W. M. W., Hui, W. S., Chu, P., Chiu, S. W., & Ip, N. Y. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02317-6 · Cited by 112
Finzer, P., Kuntzen, C., Soto, U., Hausen, H. Z., & Rösl, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204652 · Cited by 112
Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells
Liu, G., Bibus, D. M., Bode, A. M., Ma, W., Holman, R. T., & Dong, Z. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131195198 · Cited by 111
Pineau, T., Hudgins, W. R., Liu, L., Chen, L., Sher, T., Gonzalez, F. J., & Samid, D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00340-1 · Cited by 110
Huang, H., Reed, C. P., Zhang, J. S., Shridhar, V., Wang, L., & Smith, D. I. (1999) · PubMed · Cited by 110
Sodium valproate inhibits in vivo growth of human neuroblastoma cells
Cinatl, J. J., Činátl, J., Driever, P. H., Kotchetkov, R., POUCKOVA, P., Kornhuber, B., & Schwabe, D. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199711000-00007 · Cited by 108
Self-citationBone Mineralization and Osteoblast Differentiation Are Negatively Modulated by Integrin αvβ3
Cheng, S., Lai, C.-F., Blystone, S. D., & Avioli, L. V. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.277 · Cited by 105
Valproate robustly enhances AP-1 mediated gene expression
Chen, G., Yuan, P.-X., Jiang, Y., Huang, L., & Manji, H. K. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00303-9 · Cited by 102
Herrera, R., Hubbell, S. E., Decker, S. J., & Petruzzelli, L. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3847 · Cited by 101
Multiple biological responses activated by nuclear protein kinase C
Martelli, A. M., Sang, N., Borgatti, P., Capitani, S., & Neri, L. M. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990915)74:4<499::aid-jcb1>3.0.co;2-x · Cited by 99
Koyama, Y., Adachi, M., Sekiya, M., Takekawa, M., & Imai, K. (2000) · Blood · doi:10.1182/blood.v96.4.1490 · Cited by 96
BRAIN DAMAGE AND OPEN-HEART SURGERY
Jackson, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91106-9 · Cited by 95
Rumi, M. A. K., Sato, H., Ishihara, S., Kawashima, K., Hamamoto, S., Kazumori, H., Okuyama, T., Fukuda, R., Nagasue, N., & Kinoshita, Y. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1821 · Cited by 93
Cinatl, J. J., Kotchetkov, R., Blaheta, R. A., Driever, P. H., Vogel, J., & Činátl, J. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.1.97 · Cited by 92
Self-citationXu, X., Otsuki, M., Saito, H., Sumitani, S., Yamamoto, H., Asanuma, N., Kouhara, H., & Kasayama, S. (2001) · Endocrinology · doi:10.1210/endo.142.8.8340 · Cited by 92
Complex Functions of AP-1 Transcription Factors in Differentiation and Survival of PC12 Cells
Leppä, S., Eriksson, M. R., Saffrich, R., Ansorge, W. J., & Bohmann, D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4369-4378.2001 · Cited by 91
Lithium regulates PKC‐mediated intracellular cross‐talk and gene expression in the CNS in vivo
Chen, G., Masana, M. I., & Manji, H. K. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.20303.x · Cited by 90
Kitamura, K., Hoshi, S., Koike, M., Kiyoi, H., Saito, H., & Naoe, T. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01933.x · Cited by 90
Antitumor activity of sodium valproate in cultures of human neuroblastoma cells
Cínatl, J., Činátl, J., Scholz, M., et al. (1996) · Anti-Cancer Drugs · doi:10.1097/00001813-199609000-00008 · Cited by 88
Hisatake, J., Kubota, T., Hisatake, Y., Uskoković, M. R., Tomoyasu, S., & Koeffler, H. P. (1999) · PubMed · Cited by 87
Increase in AP-1 Transcription Factor DNA Binding Activity by Valproic Acid
Guang, C. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00239-4 · Cited by 83
Asghari, V., Wang, J. F., Reiach, J. S., & Young, L. T. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00107-7 · Cited by 82
Edvardsen, K., Pedersen, P., Bjerkvig, R., Hermann, G. G., Zeuthen, J., Lærum, O. D., Waish, F. S., & Bock, E. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580119 · Cited by 78
Han, S. W., Greene, M. E., Pitts, J., Wada, R. K., & Sidell, N. (2001) · PubMed · Cited by 77
Chen, B., Wang, J., Hill, B., & Young, L. T. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00125-4 · Cited by 73
Elnemr, A., Ohta, T., Iwata, K., et al. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.6.1157 · Cited by 73
Asou, H., Verbeek, W., Williamson, E. A., Elstner, E., Kubota, T., Kamada, N., & Koeffler, H. P. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.5.1027 · Cited by 72
Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans
Hertz, R., & Bar‐Tana, J. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00290-2 · Cited by 71
Contribution of receptor/G protein signaling to cell growth and transformation
Gudermann, T. W., Grosse, R., & Schultz, G. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900208 · Cited by 69
Owens, G. C., Orr, E. A., DeMasters, B. K., Muschel, R. J., Berens, M. E., & Kruse, C. A. (1998) · PubMed · Cited by 69
Watson, D. G., Watterson, J. M., & Lenox, R. H. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37400-2 · Cited by 68
Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin
Regan, C. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90207-0 · Cited by 67
Cieslik, K. A., Abrams, C. S., & Wu, K. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005305200 · Cited by 65
Reduction of Steady‐State Valproate Levels by Other Antiepileptic Drugs
Sackellares, J. C., Sato, S., Dreifuss, F. E., & Penry, J. K. (1981) · Epilepsia · doi:10.1111/j.1528-1157.1981.tb06154.x · Cited by 65
Werling, U., Siehler, S., Litfin, M., Nau, H., & Göttlicher, M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1269 · Cited by 63
Lampen, A., Siehler, S., Ellerbeck, U., Göttlicher, M., & Nau, H. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8770 · Cited by 61
Mani, S., Shen, Y., Schaefer, J., & Meiri, K. F. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0931 · Cited by 61
Valproic acid-induced changes in gene expression during neurulation in a mouse model
Wlodarczyk, B. J., Craig, J. C., Bennett, G. D., Calvin, J. A., & Finnell, R. H. (1996) · Teratology · doi:10.1002/(sici)1096-9926(199612)54:6<284::aid-tera3>3.0.co;2-z · Cited by 61
Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype
Kim, M.-S. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00465-1 · Cited by 60
Han, S., Wada, R. K., & Sidell, N. (2001) · PubMed · Cited by 59
Tan, M., Grijalva, R., & Yu, D. (1999) · PubMed · Cited by 59
Reed, J. A., Finnerty, B., & Albino, A. P. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65150-4 · Cited by 58
Teicher, B. A., Menon, K., Álvarez, E., et al. (2001) · PubMed · Cited by 58
Abdul, M., & Hoosein, N. M. (2001) · PubMed · Cited by 58
Samid, D., Wells, M., Greene, M. E., Shen, W., Palmer, C. N., & Thibault, A. (2000) · PubMed · Cited by 57
Nawa, T., Nawa, M., Cai, Y., Zhang, C., UCHIMURA, I., Narumi, S., Numano, F., & Kitajima, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3332 · Cited by 57
Martin, M. L., & Regan, M. (1991) · Brain Research · doi:10.1016/0006-8993(91)90193-y · Cited by 55
Valproic acid for the treatment of pediatric malignant glioma
Driever, P. H., Knüpfer, M. M., Cinatl, J. J., & Wolff, J. E. A. (1999) · Klinische Pädiatrie · doi:10.1055/s-2008-1043809 · Cited by 55
Self-citationNeuronal differentiation of PC12 cells as a result of prevention of cell death by bcl‐2
Sato, N., Hotta, K., Waguri, S., Nitatori, T., Tohyama, K., Tsujimoto, Y., & Uchiyama, Y. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251005 · Cited by 55
Lampen, A., Carlberg, C., & Nau, H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01423-6 · Cited by 53
Knüpfer, M. M., Driever, P. H., Poppenborg, H., Wolff, J. E. A., & Cinatl, J. J. (1998) · PubMed · Cited by 52
Self-citationInokoshi, J., Katagiri, M., Arima, S., Tanaka, H., Hayashi, M., Kim, Y. B., Furumai, R., Yoshida, M., Horinouchi, S., & Ōmura, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0316 · Cited by 49
Sands, S., Guerra, V., & Morilak, D. A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00072-x · Cited by 47
Bruserud, Ø., Gjertsen, B. T., & Huang, T. (2000) · The Oncologist · doi:10.1634/theoncologist.5-6-454 · Cited by 47
Dual Function of Troglitazone in ICAM-1 Gene Expression in Human Vascular Endothelium
Chen, N.-G., & Han, X. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4628 · Cited by 45
Cell type‐ and promoter‐dependent modulation of the Wnt signaling pathway by sodium butyrate
Bordonaro, M., Lazarova, D. L., Augenlicht, L. H., & Sartorelli, A. C. (2001) · International Journal of Cancer · doi:10.1002/ijc.1577 · Cited by 44
Katoh, S., Mitsui, Y., Kitani, K., et al. (1999) · Biochemical Journal · doi:10.1042/bj3380465 · Cited by 43
Murphy, K. J., Fox, G. B., Foley, A., Gallagher, H. C., O'Connell, A. W., Griffin, A., Nau, H., & Regan, C. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00411.x · Cited by 42
Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
Murata, M., Towatari, M., Kosugi, H., Tanimoto, M., Ueda, R., Saito, H., & Naoe, T. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00899.x · Cited by 41
Lovat, P. E., Irving, H., Annicchiarico‐Petruzzelli, M., Bernassola, F., Malcolm, A. J., Pearson, A. D. J., Melino, G., & Redfern, C. P. F. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00242-6 · Cited by 40
Mm, K., Pulzer, F., Schindler, I., Driever, P. H., Knüpfer, H., & Keller, E. (2001) · PubMed · Cited by 37
Nojiri, H., Manya, H., Isono, H., Yamana, H., & Nojima, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00709-7 · Cited by 36
Teicher, B. A., Menon, K., Alvarez, E., Liu, P., Shih, C., & Mm, F. (2001) · PubMed · Cited by 36
Shack, S., Miller, A., Liu, L., Prasanna, P., Thibault, A., & Samid, D. (1996) · PubMed · Cited by 32
Wakabayashi, K., Saito, H., Ebinuma, H., Saito, Y., Takagi, T., Nakamura, M., Umezawa, A., Hata, J., & Ishii, H. (2000) · Oncology Reports · doi:10.3892/or.7.2.285 · Cited by 30
Courage‐Maguire, C., Bacon, C. L., Nau, H., & Regan, C. M. (1997) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(96)00069-x · Cited by 29
Peroxisome proliferator-activated receptor gamma (PPARγ) activation and its consequences in humans
Bar‐Tana, J. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00302-2 · Cited by 29
Zhu, L., Gong, B., Bisgaier, C. L., Aviram, M., & Newton, R. S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9567 · Cited by 28
Identification of mood stabilizer-regulated genes by differential-display PCR
Wang, J., Bown, C. D., Chen, B., et al. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002231 · Cited by 27
Incorporation of [3H]Valproic Acid into Lipids in GT1–7 Neurons
Siafaka‐Kapadai, A., Patiris, M., Bowden, C. L., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00148-8 · Cited by 26
Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
Jalava, A., & Mai, S. (1994) · PubMed · Cited by 26
Marianna, P., Κollia, P., Akel, S. M., PAPASSOTIRIOU, Y., Stamoulakatou, A., & Loukopoulos, D. (2001) · PubMed · Cited by 24
Burdge, G. C., RODWAY, H. A., Kohler, J. A., & Lillycrop, K. A. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010201)80:2<266::aid-jcb160>3.0.co;2-6 · Cited by 22
Up-regulation of Jun/AP-1 during differentiation of N1E-115 neuroblastoma cells.
de Groot, R. P., & Kruijer, W. (1991) · PubMed · Cited by 21
Xu, X. (2001) · Endocrinology · doi:10.1210/en.142.8.3332 · Cited by 21
In vitro screening for anticonvulsant‐induced teratogenesis: Drug alteration of cell adhesivity
Maguire, C., & Regan, C. M. (1991) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(91)90019-i · Cited by 13
(2001) · PubMed
(1999) · doi:10.1002/(sici)1521-1878(199912)22:1<1021::aid-bies6>3.0.co;2-p
Cited by
Histone Deacetylase Inhibitors as Anticancer Drugs
Eckschlager, T., Plch, J., Stiborova, M., & Hrabeta, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071414 · Cited by 1,206
Hsieh, J., Nakashima, K., Kuwabara, T., Mejia, E., & Gage, F. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407643101 · Cited by 719
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.-P., & Göttlicher, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00114-x · Cited by 525
Nuclear Receptor Coregulators: Judges, Juries, and Executioners of Cellular Regulation
Lonard, D. M., & O'Malley, B. W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.012 · Cited by 494
Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation
Gurvich, N., Tsygankova, O. M., Meinkoth, J. L., & Klein, P. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0799 · Cited by 459
Metadata
- Authors
- Blaheta, R. A., & Cinatl, J.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2002-07-30
- Volume
- 22
- Issue
- 5
- Pages
- 492-511
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2108743126
- Cited by
- 269
- References
- 153
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.